Health Care
More on Health Care
WASHINGTON—The Co-Chairs of the Blue Dog Coalition—Reps. Tom O'Halleran (AZ-01), Ed Case (HI-01), Stephanie Murphy (FL-07), and Kurt Schrader (OR-05) issued the following statement on the passage of the Inflation Reduction Act:
WASHINGTON—Today, the House passed the bipartisan, bicameral Seeding Rural Resilience Act, which was included in the National Defense Authorization Act (NDAA). Endorsed by the Blue Dog Coalition, the Seeding Rural Resilience Act helps to address the growing rate of suicide in rural communities across the country.
WASHINGTON—Today, the Blue Dog Coalition's Co-Chair for Administration, Rep. Stephanie Murphy (FL-07), issued the following statement on House passage of the Paycheck Protection Program and Health Care Enhancement Act:
WASHINGTON—Today, the Democratic Blue Dog Coalition announced its endorsement of the bipartisan, bicameral H.R. 2815,Training the Next Generation of Primary Care Doctors Act, a bill that would improve access to physicians in rural communities. Specifically, the legislation reauthorizes and expands the Teaching Health Center Graduate Medical Education (THCGME) Program to address the physician shortage facing communities across the country. The bill was introduced in the House by Rep.
WASHINGTON—The Democratic Blue Dog Coalition has endorsed the bipartisan, bicameral Seeding Rural Resilience Act, which helps to address the growing rate of suicide in rural communities across the country. The bill was introduced in the House by Blue Dog Coalition Co-Chair for Whip, Rep. Anthony Brindisi (NY-22), as well as Reps. John Katko (NY-24) and Angie Craig (MN-02). The companion bill in the Senate is sponsored by Senators Jon Tester (D-MT) and Chuck Grassley (R-IA).
WASHINGTON—Today, the House passed two prescription drug pricing bills with bipartisan support, which were endorsed by the Blue Dog Coalition earlier this month. The legislation was endorsed as part of the Coalition's effort to call on Congress to take up a series of additional, bipartisan prescription drug pricing bills that, if taken up individually, could pass a Democratic-led House and a Republican-led Senate.